Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank67
3Y CAGR-22.2%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-22.2%/yr
Quarterly compound
Percentile
P67
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 2.63% |
| Q2 2025 | 471.01% |
| Q1 2025 | -88.11% |
| Q4 2024 | 58.01% |
| Q3 2024 | 8.08% |
| Q2 2024 | 15.46% |
| Q1 2024 | -25.54% |
| Q4 2023 | -5.34% |
| Q3 2023 | 107.97% |
| Q2 2023 | -57.69% |
| Q1 2023 | 3109.39% |
| Q4 2022 | -97.16% |
| Q3 2022 | 5.59% |
| Q2 2022 | 41.94% |
| Q1 2022 | 19.08% |
| Q4 2021 | 108.53% |
| Q3 2021 | -7.81% |
| Q2 2021 | 68.05% |
| Q1 2021 | 557.74% |
| Q4 2020 | -39.57% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |